2 - TI Pharma

31. Henriksen jE, Alford F, Vaag A, Handberg A, Beck-Nielsen H. Intracellular skeletal muscle glucose
metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type
2 diabetic patients. Metabolism. 1999;48(9):1128-35.
32. Ekstrand A, Schalin-jantti C, Lofman M, Parkkonen M, Widen E, Franssila-Kallunki A, Saloranta
C, Koivisto, Groop L. The effect of (steroid) immunosuppression on skeletal muscle glycogen
metabolism in patients after kidney transplantation. Transplantation. 1996;61(6):889-93.
33. Lofberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, Bergstrom J, Alvestrand
A. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in
human muscle. Eur j Clin Invest. 2002;32(5):345-53.
34. Patti ME, Brambilla E, Luzi L, Landaker Ej, Kahn CR. Bidirectional modulation of insulin action by
amino acids. j Clin Invest 1998;101(7):1519-29.
35. Schakman O, Gilson H, Thissen jP. Mechanisms of glucocorticoid-induced myopathy. j Endocrinol.
2008;197(1):1-10.
36. Dinneen S, Alzaid A, Miles j, Rizza R. Effects of the normal nocturnal rise in cortisol on carbohydrate
and fat metabolism in IDDM. Am j Physiol. 1995;268(4 Pt 1):E595-603.
37. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the
development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32 Suppl 3:14-23.
38. Randle Pj, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin
sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1(7285):785-9.
39. Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am j Physiol
Endocrinol Metab. 2003;285(4):E685-92.
40. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci
(Lond) 1999;96(5):513-23.
41. Nielsen MF, Caumo A, Chandramouli V, Schumann WC, Cobelli C, Landau BR, Vilstrup H, Rizza
RA, Schmitz O. Impaired basal glucose effectiveness but unaltered fasting glucose release and
gluconeogenesis during short-term hypercortisolemia in healthy subjects. Am j Physiol Endocrinol
Metab. 2004;286(1):E102-E110.
42. Rooney DP, Neely RD, Cullen C, Ennis CN, Sheridan B, Atkinson AB, Trimble ER, Bell PM. The effect of
cortisol on glucose/glucose-6-phosphate cycle activity and insulin action. j Clin Endocrinol Metab.
1993;77(5):1180-3.
43. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol.
2007;275(1-2):43-61.
44. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S. The diabetogenic effects of glucocorticoids are more
pronounced in low- than in high-insulin responders. Proc Natl Acad Sci U S A. 1992;89(13):6035-9.
45. Miyoshi H, Shulman GI, Peters Ej, Wolfe MH, Elahi D, Wolfe RR. Hormonal control of substrate cycling
in humans. j Clin Invest. 1988;81(5):1545-55.
43
2
Chapter 2